A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease

GM Leyden, TR Gaunt, TG Richardson - medRxiv, 2020 - medrxiv.org
Importance New drugs which provide benefit alongside statin mono-therapy are warranted
to reduce risk of cardiovascular disease. Objective To systematically evaluate the genetically …
被引用次数：2 相关文章

A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease

GM Leyden, TR Gaunt, TG Richardson - 2020 - europepmc.org
A factorial Mendelian randomization study to systematically prioritize genetic targets for the
treatment of cardiovascular disease - Abstract - Europe PMC Sign in | Create an account …